EXELON

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug EXELON contains one active pharmaceutical ingredient (API):

1	Rivastigmine hydrogen tartrate UNII 9IY2357JPE - RIVASTIGMINE TARTRATE
	Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones. Thus, rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficits in dementia associated with Alzheimer’s disease and Parkinson’s disease.
	Read more about Rivastigmine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EXELON Transdermal patch	MPI, EU: SmPC	European Medicines Agency (EU)
EXELON Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06DA03	Rivastigmine	N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10538P, 10541T, 11901J, 11903L, 11904M, 11912Y, 11916E, 11923M, 11925P, 2475G, 2477J, 2493F, 2494G, 2526Y, 2551G, 8497F, 8498G, 8499H, 8500J, 9161E, 9162F
BR	Câmara de Regulação do Mercado de Medicamentos	526506001119312, 526506005130310, 526506006110313, 526506010118315, 526506012110311, 526529601171314, 526529602178312, 526529603174310, 526529604170319, 526529606173315, 526529607171316
CA	Health Products and Food Branch	02242115, 02242116, 02242117, 02242118, 02245240, 02302845, 02302853, 02432803
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00200466, 01352178, 01352310, 03719298, 04033864, 06407524, 06588856, 06733637, 06733643, 06733666, 06733672, 06830091, 06830116, 07343016, 08608534, 08608563, 08608600, 08608646, 09777457, 09777463, 09929588, 09929594, 10005458, 10005470, 10005518, 10005553, 10202905, 10202928, 10204117, 10286799, 10398707, 10398713, 10398736, 10398742, 10408268, 10408274, 10408280, 10408297, 10411678, 10547254, 10547260, 10547277, 10709538, 10709544, 10712374, 10792404, 10792433, 10792456, 10792462, 11095541, 11095558, 11220673, 11340012, 11340035, 11702805, 12381415, 12381421, 12381438, 12381444, 12381450, 12615652, 13197665, 13197671, 13570928, 13631009, 13631021, 13650828, 14242445
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28522-07-08
EE	Ravimiamet	1043345, 1074462, 1074473, 1074484, 1074495, 1074507, 1074518, 1074585, 1074596, 1074608, 1074619, 1074620, 1074631, 1308282, 1308293, 1308305, 1308316, 1308327, 1351257, 1351268, 1351279, 1351280, 1351291, 1351303, 1351314, 1351325, 1645040, 1645051, 1645062, 1645073, 1645084, 1645095, 1645107, 1645118
ES	Centro de información online de medicamentos de la AEMPS	198066029, 98066001, 98066002, 98066003, 98066005, 98066006, 98066008, 98066009, 98066011, 98066012, 98066013, 98066020, 98066025
FI	Lääkealan turvallisuus- ja kehittämiskeskus	082776, 083634, 096260, 096670, 096679, 096697, 116669, 125713, 153145, 173007, 444511, 491639, 523931, 573435
FR	Base de données publique des médicaments	61689033, 63093669, 64708108, 67070657, 67402045, 67885398, 69850613
GB	Medicines & Healthcare Products Regulatory Agency	122350, 122353, 180581, 185782, 185784, 223844, 367996, 367998, 374366, 374368, 390261
HK	Department of Health Drug Office	43308, 43309, 43310, 43311, 56982, 56983, 62812
IE	Health Products Regulatory Authority	23200, 23269, 23311, 23332, 23365, 23397, 24410, 24417, 24420, 24421, 24422, 24441, 24487, 24488, 24490, 24491, 55528
IL	מִשְׂרַד הַבְּרִיאוּת	3633, 3634, 4564, 4565, 6221, 6223, 7369
IT	Agenzia del Farmaco	034078028, 034078055, 034078081, 034078117, 034078168, 034078206, 034078283, 034078360, 034078408, 034078446
JP	医薬品医療機器総合機構	1190700S1029, 1190700S2025, 1190700S3021, 1190700S4028
LT	Valstybinė vaistų kontrolės tarnyba	1006532, 1008717, 1008718, 1008719, 1008720, 1008721, 1008722, 1008723, 1008724, 1028074, 1028075, 1028076, 1028077, 1028078, 1028079, 1028080, 1028081, 1028082, 1028083, 1028084, 1028085, 1028086, 1028087, 1028088, 1028089, 1028090, 1070403, 1070404, 1070405, 1070406, 1075198, 1075199, 1075200, 1080527, 1088714, 1088715, 1088716, 1088717, 1088718, 1088719, 1088720, 1088721, 1088722, 1088723, 1088724, 1088725, 1088726, 1088727, 1088728, 1088729
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	293M2007
NL	Z-Index G-Standaard, PRK	105414, 50164, 50172, 50180, 50199, 84980, 85006
NZ	Medicines and Medical Devices Safety Authority	13002, 13003, 13004, 13005, 8004, 8005, 8006, 8007, 8710
PL	Rejestru Produktów Leczniczych	100000592, 100001433, 100083566, 100084471, 100086501, 100090655, 100092973, 100179088
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64473001, W64473002, W64473003, W64473004, W64473005, W64474001, W64474002, W64474003, W64474004, W64474005, W64475004, W64475005, W64475006, W64475007, W64475008
SG	Health Sciences Authority	10035P, 10036P, 10037P, 10038P, 13450P, 13451P, 14500P
TN	Direction de la Pharmacie et du Médicament	10283204H, 10283221, 10283221H, 10283222H, 10283223H, 10283224H, 10283225H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504150254, 8699504150308, 8699504150353, 8699504150407, 8699504590258, 8699504810455, 8699504810509, 8699504810547
US	FDA, National Drug Code	0078-0323, 0078-0324, 0078-0325, 0078-0326, 0078-0501, 0078-0502, 0078-0503
ZA	Health Products Regulatory Authority	32/5.3/0455